Cite
MLA Citation
Y. Urun et al.. “3354 Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study.” European journal of cancer, vol. 51, n.d., pp. S686–S687. http://access.bl.uk/ark:/81055/vdc_100030687863.0x00005e